Severe or unusual symptoms - particularly those involving cardiac, pancreatic, or thyroid concerns - should prompt immediate contact with a healthcare provider
[1] [5] Ensure you recognise hypoglycaemia symptoms (tremor, sweating, confusion, palpitations) Gallbladder problems : Report symptoms such as right upper abdominal pain, fever, or jaundice Diabetic retinopathy complications : Patients with pre-existing retinopathy should have regular eye examinations Important safety warnings: Pregnancy and breastfeeding : GLP-1 receptor agonists are not recommended during pregnancy or breastfeeding
Dieting didnt help, and I was frustrated
2020;31(11891205):e13
It is available as monotherapy in both subcutaneous as well as oral dosage form (first approved oral GLP-1 receptor agonist)
Answer: Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications that includes semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Zepbound, Mounjaro), liraglutide (Victoza, Saxenda), and orforglipron (Foundayo), have become increasingly popular for obesity treatment (Mehrtash, JAMA Intern Med 2025)